Human Papillomavirus (HPV) News and Research

Latest Human Papillomavirus (HPV) News and Research

Immunogenicity and safety of human papillomavirus vaccine in healthy boys

New industry-supported research from Finland suggests that Cervarix, an HPV vaccine given to girls in Europe and elsewhere, is safe for boys as well.

21 Dec 2008

Male circumcision may help prevent human papillomavirus infection

Two new studies suggest that male circumcision may assist in the prevention of human papillomavirus (HPV) infection, particularly infection with the high-risk subtypes associated with cervical, penile, and other cancers.

17 Dec 2008

Promiscuity fears pose barrier to cervical cancer vaccinations

The public's concerns about costs and increased promiscuity among teenagers appear to be hindering use of a vaccine against the human papilloma virus (HPV) to prevent life-threatening diseases, according to a study by researchers at Yale School of Public Health.

17 Dec 2008

Conquering cancer: A global effort

Despite the recent good news that cancer incidence and death rates for men and women in the United States continue to decline, cancer is projected to become the leading cause of death worldwide in the year 2010, and low- and middle-income countries will feel the impact of higher cancer incidence and death rates more sharply than industrialized countries.

10 Dec 2008

Genetic breakdown in Fanconi anemia may have link to HPV-associated cancer

A genetic malfunction that causes DNA instability in people with the blood disorder Fanconi anemia may put them at high risk for squamous cell carcinomas linked to human papillomavirus (HPV), according to a study posted online ahead of print by Oncogene.

3 Dec 2008

Reactions to HPV vaccine Gardasil rare

Research by Australian scientists has found that adverse reactions to the HPV vaccine Gardasil are rare and most schoolgirls are able to tolerate subsequent doses.

3 Dec 2008

European research effort pushes towards cervical cancer cure

Every year, tens of thousands of women die in the EU from cervical cancer because the disease is not detected and treated at an early enough stage. A multidisciplinary European research effort plans to change that.

2 Dec 2008

Living in deprived areas of England doubles cervical cancer risk

Women living in the most deprived areas of England are nearly twice as likely to be diagnosed with cervical cancer than their affluent counterparts - according to a report presented by national cancer director Professor Mike Richards at the Britain Against Cancer conference today (Tuesday).

2 Dec 2008

Survival of head and neck cancer patients is greatly affected by coexisting ailments

Current estimates for head and neck cancer survival are largely inaccurate because they widely disregard many of the most common diseases such patients have in addition to their primary cancer, says Jay Piccirillo, M.D., a head and neck specialist at Washington University School of Medicine in St. Louis, the Siteman Cancer Center and Barnes-Jewish Hospital.

19 Nov 2008

Adults need vaccines to protect from preventable diseases, say medical societies

The American College of Physicians (ACP) and the Infectious Diseases Society of America (IDSA) have released a joint statement on the importance of adult vaccination against an increasing number of vaccine-preventable diseases.

19 Nov 2008

Vaccine-related chronic fatigue syndrome in an individual demonstrating aluminium overload

A team of scientists have investigated a case of vaccine-associated chronic fatigue syndrome (CFS) and macrophagic myofasciitis in an individual demonstrating aluminium overload.

18 Nov 2008

Researchers say identifying women with HPV types 16, 18 and 45 could improve early intervention to stop cervical cancer

As testing for high-risk types of the human papillomavirus (HPV) emerges as the gold standard in cervical cancer prevention, scientists are already researching how to determine even more precisely who is most likely to develop the disease and thus are in need of more immediate intervention.

16 Nov 2008

State mandates for HPV vaccination unwarranted and unwise

The HPV vaccine, sold as Gardasil in the U.S., is intended to prevent four strains of the human papillomavirus, the most common sexually transmitted infection in the world.

12 Nov 2008

Expert warns it would be ill-advised to mandate HPV vaccinations at this time

Vaccinating girls against the human papillomavirus (HPV) before they are sexually active appears to be successful in protecting them against cervical cancer, however, a Johns Hopkins University researcher and health policy expert warns it would be ill-advised to mandate vaccinations at this time.

12 Nov 2008

Comprehensive assessment of burden of HPV-associated cancers in the U.S.

Professor Vivien Chen, PhD,. Associate Professor Xiao Cheng Wu, MD, PhD and Assistant Professor Edward Peters, DMD, SM, ScD, at LSU Health Sciences Center New Orleans School of Public Health contributed five papers to the largest most comprehensive assessment of the burden of human papillomavirus (HPV)-associated cancers in the United States to date.

11 Nov 2008

Most adults not up to date on their vaccinations

Most adults are not up to date on their vaccinations, says a new report from Harvard Medical School.

5 Nov 2008

Call to explore broader use of human papillomavirus vaccines

A call to explore a broader use of HPV (human papillomavirus) vaccines and the validation of a simple oral screening test for HPV-caused oral cancers are reported in two studies by a Johns Hopkins Kimmel Cancer Center investigator.

4 Nov 2008

Human papillomavirus helps cervical and head and neck cancers resist treatment and grow and spread

The human papillomavirus (HPV) allows infected cervical and head and neck cancer cells to maintain internal molecular conditions that make the cancers resistant to therapy and more likely to grow and spread, resulting in a poor prognosis for patients, researchers with UCLA's Jonsson Cancer Center found.

4 Nov 2008

Scientist says research indicates need for effective HPV vaccine for women and men and a simple HPV screening test

3 Nov 2008

Gardasil safety questioned, CDC urged to back up statement with data

The National Vaccine Information Center (NVIC) is calling on the Centers for Disease Control (CDC) and Food and Drug Administration (FDA) to publicly release the study design, data and names of principal investigators involved in a statement this week maintaining that Gardasil vaccine is safe with no serious side effects.

26 Oct 2008

Human Papillomavirus (HPV) News and Research

Latest Human Papillomavirus (HPV) News and Research

Immunogenicity and safety of human papillomavirus vaccine in healthy boys

Male circumcision may help prevent human papillomavirus infection

Promiscuity fears pose barrier to cervical cancer vaccinations

Conquering cancer: A global effort

Genetic breakdown in Fanconi anemia may have link to HPV-associated cancer

Reactions to HPV vaccine Gardasil rare

European research effort pushes towards cervical cancer cure

Living in deprived areas of England doubles cervical cancer risk

Survival of head and neck cancer patients is greatly affected by coexisting ailments

Adults need vaccines to protect from preventable diseases, say medical societies

Vaccine-related chronic fatigue syndrome in an individual demonstrating aluminium overload

Researchers say identifying women with HPV types 16, 18 and 45 could improve early intervention to stop cervical cancer

State mandates for HPV vaccination unwarranted and unwise

Expert warns it would be ill-advised to mandate HPV vaccinations at this time

Comprehensive assessment of burden of HPV-associated cancers in the U.S.

Most adults not up to date on their vaccinations

Call to explore broader use of human papillomavirus vaccines

Human papillomavirus helps cervical and head and neck cancers resist treatment and grow and spread

Scientist says research indicates need for effective HPV vaccine for women and men and a simple HPV screening test

Gardasil safety questioned, CDC urged to back up statement with data

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Human Papillomavirus (HPV) News and Research

Latest Human Papillomavirus (HPV) News and Research

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Newsletters you may be interested in